<DOC>
	<DOC>NCT01545037</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of Bio-K+ on symptoms of IBS.</brief_summary>
	<brief_title>Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome</brief_title>
	<detailed_description>Given the promising clinical results of previous trials of probiotics for IBS symptoms, the objective of this clinical trial is to evaluate the safety and effectiveness of a proprietary probiotic product, Lactobacillus acidophilus CL1285® and Lactobacillus casei LBC80R®, on symptoms of IBS in otherwise healthy adults.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>1. Age 18 years or older 2. Subject meets Rome III criteria for IBS (regardless of IBS subtype) as follows: Recurrent abdominal pain or discomfort at least 3 days/month in the last 3 months associated with 2 or more of the following: Improvement with defecation Onset associated with a change in frequency of stool Onset associated with a change in form (appearance) of stool Symptom onset must be at least 6 months prior to diagnosis 3. Agree to use contraception throughout study period, unless postmenopausal or surgically sterile (females only) 4. Able to understand the nature and purpose of the study including potential risks and side effects 5. Willing to consent to study participation and to comply with study requirements Abdominal pain or discomfort at least 2 days during runin period associated with 2 or more of the following: Improvement with defecation Onset associated with a change in frequency of stool Onset associated with a change in form (appearance) of stool Completion of all studyrelated questionnaires 1. Diagnosed gastrointestinal disease, e.g. Crohn's disease, ulcer, cancer 2. Prior abdominal surgery that, in the investigator's opinion, may confound study outcomes 3. Any systemic disease that may confound IBS symptoms or compromise subject safety 4. Life expectancy &lt; 6 months 5. Pregnant female or breastfeeding 6. Lactose intolerance 7. Immunodeficient subjects 8. Uncontrolled psychiatric disorder 9. Current treatment with nasogastric tube, ostomy, or parenteral nutrition 10. Eating disorder 11. Recent (&lt; 2 weeks) antibiotic administration 12. History of alcohol, drug, or medication abuse 13. Daily consumption of probiotics, fermented milk, and/or yogurt 14. Known allergies to any substance in the study product 15. Participation in another study with any investigational product within 3 months of screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>